Sulphadimidine, pyrimethamine and dapsone in the treatment of toxoplasmosis in mice.
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D003622:Dapsone; D004359:Drug Therapy, Combination; D051379:Mice; D011739:Pyrimethamine; D013418:Sulfamethazine; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000494:pharmacology*; D013450:Sulfones / Q000494:pharmacology*; D014122:Toxoplasma; D014123:Toxoplasmosis
D000962:Antimalarials; D013424:Sulfanilamides; D013449:Sulfonamides; D013450:Sulfones; D000077145:Sulfanilamide; D013418:Sulfamethazine; D003622:Dapsone; D011739:Pyrimethamine
ANTIMALARIALS/effects; SULFONAMIDES/effects; SULFONES/effects; TOXOPLASMOSIS/experimental
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):467-73; discussion, 498-508
12995436
J Pharmacol Exp Ther. 1953 Jan;107(1):92-130
13035647
Br J Pharmacol Chemother. 1950 Dec;5(4):565-83
14801463
Proc Soc Exp Biol Med. 1951 Mar;76(3):548-51
14844269
Public Health Rep. 1952 Mar;67(3):249-52
14900360
Am J Trop Med Hyg. 1949 Nov;29(6):889-93
15395138